Today: 2 March 2026
Subscribe
Browse Category

Mergers & Acquisitions 18 November 2025 - 21 November 2025

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Pfizer has closed its $10 billion acquisition of Metsera, paying $65.60 per share plus a contingent value right of up to $20.65 per share. Metsera shares stopped trading on Nasdaq after November 13. On November 21, Pfizer raised $6 billion through a seven-tranche bond sale to help fund the deal. Metsera is now a Pfizer subsidiary.
21 November 2025
···
Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri Corporation will sell its Clean Earth hazardous-waste unit to Veolia Environnement for $3.04 billion in cash and spin off its remaining businesses into a new public company, New Enviri. NVRI shares jumped over 30% in premarket trading. Shareholders are set to receive $14.50–$16.50 per share in cash plus 0.33 shares of New Enviri for each Enviri share. The deal is expected to close by mid-2026.
21 November 2025
···
Ondas Holdings (ONDS) Jumps on $35M PDW Combat Robotics Deal as Sentrycs Acquisition Reshapes Drone-Defense Strategy – 21 November 2025

Ondas Holdings (ONDS) Jumps on $35M PDW Combat Robotics Deal as Sentrycs Acquisition Reshapes Drone-Defense Strategy – 21 November 2025

Ondas Holdings invested $35 million in Performance Drone Works to expand U.S. combat drone production and closed its acquisition of Sentrycs, an Israeli counter‑drone tech firm. Ondas reported record Q3 revenue of $10.1 million and raised 2025 guidance to at least $36 million. Shares remain volatile, trading near $6 after sharp swings, but are up several hundred percent over the past year.
21 November 2025
···
Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories announced a deal to acquire Exact Sciences for $105 per share in cash, valuing the company at about $21 billion in equity and $23 billion including debt. The boards of both companies approved the transaction, which is expected to close in Q2 2026 pending regulatory and shareholder approval. Exact Sciences stock surged, while Abbott shares dipped slightly.
20 November 2025
··
Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott will acquire Exact Sciences for $105 per share in cash, valuing the deal at about $23 billion including debt. The boards of both companies approved the transaction, which is set to close in the second quarter of 2026 pending shareholder and regulatory approval. Exact Sciences will become a subsidiary, expanding Abbott’s diagnostics revenue and portfolio. The offer represents a 21–22% premium to Exact’s last closing price.
20 November 2025
··
Spectris PLC Share Price Today (20 November 2025): LON:SXS Holds Just Below £41.75 KKR Takeover Price

Spectris PLC Share Price Today (20 November 2025): LON:SXS Holds Just Below £41.75 KKR Takeover Price

Spectris shares traded at 4,108.0p on Thursday, up 2p, with about £9.5 million in turnover. The price sits just 1.6% below the £41.75 per share cash offer from KKR. Jefferies International disclosed a 1.216% long and 1.14% short position in Spectris as of 19 November. Trading remains focused on takeover-related filings rather than company news.
20 November 2025
··
Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

PANW Stock Today (Nov 19, 2025): Palo Alto Networks beats Q1, announces $3.35B Chronosphere deal; shares swing after hours

Palo Alto Networks reported Q1 revenue of $2.47 billion, up 16%, and non-GAAP EPS of $0.93, beating analyst expectations. The company agreed to acquire Chronosphere for $3.35 billion in cash and equity, with the deal expected to close in the second half of FY26. PANW shares traded around $199.90 after hours, swinging between $186.69 and $211.64 on heavy volume. Mark Goodburn was appointed to the board.
19 November 2025
···
Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Palo Alto Networks said it will acquire Chronosphere for $3.35 billion in cash and equity, aiming to close the deal in the second half of fiscal 2026 pending regulatory approval. Chronosphere reported over $160 million in annual recurring revenue as of September 2025 and was named a Leader in the 2025 Gartner Magic Quadrant for Observability Platforms.
19 November 2025
····
EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

Exact Sciences shares surged as much as 28% on November 19 after reports that Abbott Laboratories is in advanced talks to acquire the company. EXAS hit a new 52-week high of $89.67 before settling near $81.79, up 17% by mid-afternoon. Trading volume exceeded 10.4 million shares, with about $645 million in stock changing hands. Negotiations could still face delays or collapse, according to sources.
19 November 2025
··
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire Exact Sciences, sources told Bloomberg on Wednesday, in what would be Abbott’s largest deal since 2016. Exact Sciences shares surged up to 29% intraday, reaching a market value near $16 billion, while Abbott stock fell around 3%. No official comments have been made by either company.
19 November 2025
···
Semrush Stock Soars 75% Today as Adobe Announces $1.9 Billion Cash Takeover – What SEMR Investors Need to Know (19 November 2025)

Semrush Stock Soars 75% Today as Adobe Announces $1.9 Billion Cash Takeover – What SEMR Investors Need to Know (19 November 2025)

Adobe will acquire Semrush for $12 per share in cash, valuing the deal at $1.9 billion. Semrush stock surged 74% to $11.79 after the announcement, with trading volume spiking into the tens of millions of shares. The boards of both companies approved the deal, and holders of over 75% of Semrush voting power have agreed to support it. The acquisition is expected to close in the first half of 2026.
19 November 2025
···
Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings shares traded near $7.77 on November 19, 2025, down slightly but up over 1,000% from their 52-week low. The company reported Q3 revenue of $10.1 million, up from $1.48 million a year earlier, and closed the Sentrycs acquisition. Analysts highlighted rapid growth and new contracts, but flagged high expenses and dilution risk.
19 November 2025
····
Dycom Industries (DY) Soars on Earnings Beat, Higher 2026 Outlook and $1.95 Billion Data‑Center Acquisition

Dycom Industries (DY) Soars on Earnings Beat, Higher 2026 Outlook and $1.95 Billion Data‑Center Acquisition

Dycom Industries reported record Q3 fiscal 2026 results, with revenue up 14.1% to $1.452 billion and diluted EPS rising 53% to $3.63. The company raised full-year guidance and announced a $1.95 billion acquisition of Power Solutions, adding about $1 billion in annual revenue. Backlog hit $8.2 billion. Shares surged to all-time highs above $320.
19 November 2025
··
Blue Owl Capital (OWL) Scraps OBDC–OBDC II Merger as Redemption Freeze Roils the $3 Trillion Private Credit Market

Blue Owl Capital (OWL) Scraps OBDC–OBDC II Merger as Redemption Freeze Roils the $3 Trillion Private Credit Market

Blue Owl Capital has canceled the planned merger of its two private-credit funds, OBDC and OBDC II, after investor backlash and market volatility. The decision follows a freeze on redemptions at OBDC II and reports that some investors faced potential 20% paper losses if the deal proceeded. Blue Owl shares have dropped over 40% this year. OBDC II aims to reinstate its liquidity program in 2026.
19 November 2025
···
Warner Bros. Discovery (WBD) Stock Soars as $70 Billion‑Plus Takeover Race Heats Up – Paramount, Netflix & Comcast Face Bid Deadline

Warner Bros. Discovery (WBD) Stock Soars as $70 Billion‑Plus Takeover Race Heats Up – Paramount, Netflix & Comcast Face Bid Deadline

Paramount Skydance’s latest bid values Warner Bros. Discovery at $23.50 per share, about $58.2 billion, but the board is pushing for $30 per share, or $74.3 billion. WBD shares rose over 4% to $23.69 in early afternoon trading. Gulf sovereign wealth funds are being courted for financing, while Netflix and Comcast are reportedly interested in select assets. Q3 revenue fell 6% year-on-year to $9 billion, with a net loss of $148 million.
19 November 2025
··
Cheer Holding (NASDAQ: CHR) Stock Today: Tiny AI Metaverse Player Weighs Two Takeover Bids as Shares Spike Pre‑Market

Cheer Holding (NASDAQ: CHR) Stock Today: Tiny AI Metaverse Player Weighs Two Takeover Bids as Shares Spike Pre‑Market

Cheer Holding’s board has formed a special committee to review two rival cash buyout offers at $0.56 and $0.52 per Class A share, both far above today’s $0.0477 price. Shares surged over 10% pre-market but remain deep in penny-stock territory after a 65% slide in 10 days. The committee, led by Chairman Bing Zhang, has not made any decision and may hire outside advisers. No deal is assured, the company said.
19 November 2025
····
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists

Kenvue shares traded near $16.13 midday, down 0.7%, after a U.S. appeals court signaled it may revive over 500 Tylenol-autism lawsuits. A Texas judge declined to block Kenvue’s $398 million dividend, which remains set for Nov. 26. The pending Kimberly-Clark deal implies $18.83 per share for KVUE, about 14% above its current price. Volume reached 21.1 million shares by 17:32 UTC.
18 November 2025
·····
Is Warner Bros. Discovery (WBD) the Next Big Media Stock? 75% YTD Surge Sparks Buzz

WBD Stock Today: Warner Bros. Discovery Near 52-Week High as Sale Bids Heat Up (November 18, 2025)

Warner Bros. Discovery shares traded near $22.77 on November 18, up 0.1% and close to their 52-week high, as investors awaited first-round takeover bids due November 20. The stock has surged about 140% year-over-year amid reports of potential offers from Paramount Skydance, Comcast, and Netflix. The company continues a strategic review alongside plans to split into two separate businesses.
18 November 2025
··
Click Holdings (CLIK) Jumps After Acquiring Two Hong Kong HR Firms – What Investors Need to Know Today

Click Holdings (CLIK) Jumps After Acquiring Two Hong Kong HR Firms – What Investors Need to Know Today

Click Holdings (NASDAQ: CLIK) surged on November 18, 2025, after announcing all-stock acquisitions of Bowser Human Resources and Top Team Consultants in Hong Kong, issuing 2,117,606 new shares. Trading volume topped 3.5 million, with shares in the mid-$7 range. The deals could nearly triple CLIK’s share count, raising dilution concerns. Management projects around 200% sales growth in professional services.
18 November 2025
··
1 … 11 12 13 14 15 … 20
Go toTop